Blue Horizon Stem Cells

 
 

Stem cell therapy has successfully proven to regenerate the human body without the need for medicine or surgery. Patients suffering from chronic, often debilitating diseases can benefit from the regenerative properties of this emerging therapy.
The use of stem cells to treat a variety of diseases and conditions is increasing rapidly and includes the treatment of diabetes to cancer to COVID-19 to neurological conditions.
In recent years, Mesenchymal Stem Cells derived from Wharton’s Jelly in human umbilical cords have become the gold standard for stem cell therapy.
At Blue Horizon, our Wharton’s Jelly MSCs are quality assured, ethically derived, and versatile and potent. Our cells exhibit remarkable immune and anti-inflammatory, which avoids Graft v Host disease and other potential challenges that may come from using a donor’s stem cells.
Since these cells can differentiate and produce a wide variety of important proteins and growth factors, MSCs can be used to induce a patient’s own body to regenerate tissue.
There is currently promising research using MSCs for degenerative conditions such as Alzheimer’s, ALS, and Parkinson’s; autoimmune diseases including rheumatoid arthritis, lupus, MS, and diabetes; and vascular conditions like stroke and heart disease.
We are led by an accomplished scientific and medical team that draws on its relationships with international partners who have successfully treated thousands of patients with stem cell therapy.
If you are interested in learning more about these remarkable cells and how they may help you or a loved one, please contact us today.

 

• • Our research has been published in “Experimental and therapeutic medicine” cited at PubMed Central, US National Library of Medicine, National Institutes of Health; “CellR4”, the official journal of The Cure Alliance; and presented at the American Academy of Orthopedic  Surgeons (AAOS 2018 Annual Meeting, New Orleans, LA).

• • Our stem cell products evaluated in clinical studies are collected in accordance with Good Tissue Practice to ensure safety. The studies have been conducted following approval by an Investigational Research Board and in accordance with Good Clinical Practice.

• •  Our results show our cellular products are safe and effective in the improvement of symptoms related to chronic inflammation, spinal cord injury, stroke, musculoskeletal disorders and other medical conditions.

• • Multiple studies of umbilical cord blood derived stem cell therapies and adipose-derived stem cell therapies are currently under investigation in clinical trials for a wide-range of medical conditions and show promising results.
• • The Food and Drug Administration (FDA) has given us approval to proceed with our Investigational New Drug (IND) application allowing for the initiation of a clinical study of an FDA-approved cell therapy (HCP, cord blood) for treatment of acute ischemic stroke.

 

About Blue Horizon Stem Cells

World’s leader in advanced stem cell therapy

Welcome to the Blue Horizon Stem Cell Therapy Program and Research Center. We are a world leader in the research of adult stem cell therapies. BHI Stem Cells conducted more than 4,000 stem cell treatments. We are the only treatment provider approved and associated with The Wuhan University Department of Medicine.

Painless Procedure

Option of your stem cells or umbilical cord donors

The Blue Horizon Stem Cell Therapy Program ONLY utilizes stem cells from either your own body or umbilical cord donors whom have proceeded through a multiple step testing process that ensures stem cell patient safety. The procedure is virtually painless and for most patients, takes less than a few hours. We have US trained and board certified physicians on staff for your comfort.

Patient Testimonials

At just 21 years old, a devastating motorcycle accident left top athlete Greg Mucci on the sidelines while he worked through a painful recovery from a serious hip injury. After conventional medicine took his recovery as far as it could go, Brian Mehling, M.D., an orthopedic trauma surgeon and founder of Blue Horizon Stem Cells, offered Mucci the opportunity to take part in an innovative stem cell research protocol at his center in Wuhan, China to avoid a hip replacement. Through Dr. Mehling’s foundation, the Blue Horizon Charitable Foundation, Mucci received the treatment and now, at age 30, is on the field playing in a semi-pro football league.

Gerard Rem, a lifelong resident of Manhattan with an MBA from Harvard, learned about the extraordinary benefits of stem cell therapies from a friend who had traveled to China on business and received this breakthrough treatment during his stay there. Mr. Rem, a NYC-based real estate investor, was suffering from an arthritic shoulder. After researching stem cell treatments and consulting with Dr. Brian Mehling, an orthopedic trauma surgeon and chief medical officer of Blue Horizon Stem Cells and CEO of the Blue Horizon Charitable Foundation, he made the decision to travel to China to participate in a Blue Horizon research protocol.

Like typical 21 year olds, Yesenia Torres and her friends were taking a road trip to Florida. That’s when her life was changed forever. A car accident caused a suitcase to hit her in the neck, dislocating a vertebrae, and paralyzing her from the chest down. That was 18 years ago. Today, thanks to Dr. Brian Mehling and the Blue Horizon Charitable Foundation and Yesenia’s determination to seek and find innovative stem cell therapies, she is enrolled in research protocols that could allow her to experience newfound energy and mobility that she hasn’t felt in years.

Frequently Asked Questions

 

Find out your treatment options →

Fill out the simple Appointment Request form to have one of our representatives contact you immediately.